APPLICATIONS PUBLISHED 28 JANUARY 2004
Published: 1-Jun-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
A release pharmaceutical construct for gastric retention
Kos Pharmaceuticals 1383375*
Pharmaceutical formulations for sustained release
Praecis Pharmaceuticals 1383376*
Compsns including vitamin-based surfactants and methods for using same
Allergan 1383377*
Restoration of cancer-suppressing functions to neoplastic cells through DNA hypomethylation
SuperGen 1383379*
Fizz1 for metabolism regulation
Genentech 1383380*
Use of PPAR-gamma ligands or agonists to prevent the rupture of atherosclerotic plaques
Merck 1383385*
Improved anti-inflammatory herbal compsns and method of use
New Chapter 1383386*
pH-sensitive mucoadhesive film-forming gels and wax-film composites
University of Kentucky Research Foundation 1383479*
Lipid-comprising drug delivery complexes and methods for the production
Targeted Genetics Corp; Emerald Gene Systems 1383480*
Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
University of British Columbia 1383481*
Method for manufacturing a low-dose pharmaceutical compsn
Pfizer Products 1383482*
Controlled delivery of tetracycline compounds and tetracycline derivatives
Collagenex Pharmaceuticals 1383483*
Medicinal tablet with prolonged release of the active principle
Pierre Fabre Medicament 1383484*
Gastric juice-resistant device for releasing mucoadhesive active substance excipients and method for producing the gastric juice-resistant device
LTS Lohmann Therapie-Systeme 1383485*
Compsns containing CGMP PDE inhibitors and local anaesthetic agents for nasal application
Bayer HealthCare 1383486*
Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain
Schwarz Pharma 1383487*
Methods for synthesising phenol-containing compounds
SmithKline Beecham 1383488*
Carbamate compounds for use in preventing or treating neurodegenerative disorders
Ortho-McNeil Pharmaceuticals 1383489*
Combination of epothilone analogues and chemotherapeutic agents for the treatment of proliferative diseases
Bristol-Myers Squibb 1383490*
Synergistic combinations of retinoid ligands and selected cytotoxic agents for treatment of cancer
Bristol-Myers Squibb 1383491*
Molecular conjugates for use in treatment of cancer
Napro Biotherapeutics 1383492*
Inhibition of pigmentation by inhibition of fatty acid synthase
New York University 1383493*
Compsns and methods for the prevention and treatment of human prostate cancer
Bioadvantex Pharma 1383494*
Duloxetine for treatment of hot flashes
Eli Lilly 1383495*
Treatment of fibromyalgia and related fatigue syndromes using pindolol
Dinan, Timothy; Keeling, PWN 1383496*
Carbonic anhydrase activators for enhancing learning and memory
Blanchette Rockefeller Neurosciences Institute 1383497*
CRF receptor antagonists
Glaxo Group 1383498*
Method of immunomodulation using thione-forming disulphides
Grassetti, Davide 1383499*
Compsn and method for the treatment of respiratory disease
Kaura, Sita 1383500*
Acylated piperidine derivatives as melanocortin-4 receptor agonists
Merck 1383501*
Compounds and methods for the treatment of urogenital disorders
Cellegy Pharmaceuticals 1383502*
